会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明公开
    • Substituted N-biphenylyl lactams
    • 取代基N-二苯基甲酰胺。
    • EP0542554A1
    • 1993-05-19
    • EP92310353.5
    • 1992-11-12
    • ORTHO PHARMACEUTICAL CORPORATION
    • Murray, William V.Wachter, Michael P.
    • C07D209/72C07D211/86C07D221/20C07D491/08C07D401/10C07D403/10A61K31/445
    • C07D401/10C07D209/46C07D209/74C07D211/86C07D403/10
    • This invention relates to novel N-biphenylyl lactam compounds having a substituted methylidene or methyl moiety adjacent to the lactam nitrogen, and pharmaceutically acceptable salts thereof.
      The compounds are angiotensin II receptor antagonists, and are useful in treating hypertension (lowering high blood pressure), congestive heart failure, elevated ocular pressure, cerebral stroke, angina, cardiac insufficiency, myocardial infarction or diabetic nephropathy.
      The invention also relates to a pharmaceutical composition comprising a compound of the invention, a method of treating a physiological condition in a mammal that is mediated by angiotensin II which comprises administering to the mammal an effective amount of a compound of the invention, and novel processes for preparing the compounds of the invention.
    • 本发明涉及具有邻近内酰胺氮的取代亚甲基或甲基部分的新型N-联苯酰基内酰胺化合物及其药学上可接受的盐。 这些化合物是血管紧张素II受体拮抗剂,可用于治疗高血压(降低高血压),充血性心力衰竭,眼压升高,脑中风,心绞痛,心功能不全,心肌梗塞或糖尿病肾病。 本发明还涉及包含本发明化合物的药物组合物,一种治疗由血管紧张素II介导的哺乳动物的生理状态的方法,其包括向哺乳动物施用有效量的本发明化合物和新方法 用于制备本发明的化合物。